Search Results 2441-2450 of 17039 for pharmacogenetics
When Emery Diffendorfer was a baby, he couldn't hold his head up or babble like other infants his age. His rare genetic disorder enlarged his[...] ...
Areas of study have included: Leading a multicenter, multinational trial to compare drug therapy with cardiac ablation for people with heart rhythm disease.
The purpose of this study is to determine the optimal dose of FLU-IGIV based upon evaluation of safety and pharmacokinetics in hospitalized patients with ...
Mayo Clinic to sequence 100K participants to build genomic database for improved care and research in · Genetic testing provides insights to sudden unexplained ...
About this study. This is a Phase 2b, global, multicenter, sequential, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study in ...
Learn about the training opportunities available in Dr. Rodriguez-Bravo's Genome Function, Stability and Nuclear Organization in Cancer at Mayo Clinic.
An estimated 55 million people are believed to be living with dementia, according to health officials. Vascular diseases contribute to approximately 25% of ...
As hurricane season ramps up, emergency management officials recommend that residents in coastal communities plan for an active few months.
Burlile JF, Cameron J, Gunn H, Larson N, Boughey JC, Mrdutt MM, Couch F, Olson JE, Bradt JL, Sharifzadeh Y, Ruddy KJ, Shumway D, Loprinzi CL, Cathcart-Rake EJ.
Author Correction: Cortical microstructural abnormalities in dementia with Lewy bodies and their associations with Alzheimer's disease copathologies. NPJ ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.